Moolec Science (MLECW) Amortizatization of Intangibles (2023 - 2024)
Moolec Science (MLECW) posted Amortizatization of Intangibles of $239265.0 for Q4 2024, up 0.63% sequentially from $237773.0 in Q3 2024, and up 21.85% YoY from $196354.0 in Q1 2024.
Moolec Science (MLECW) Amortizatization of Intangibles (2023 - 2024) Analysis & Trends
Moolec Science has reported Amortizatization of Intangibles for 2 years, with the latest figure at $239265.0 in Q4 2024.
- Quarterly Amortizatization of Intangibles rose 21.85% year-over-year to $239265.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $854066.0 (changed N/A YoY) and the FY2024 annual result came in at $713374.0, up 654.76% from the prior year.
- Amortizatization of Intangibles climbed to $239265.0 in Q4 2024 per MLECW's latest filing, from $237773.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $239265.0 in Q4 2024 and troughed at $139992.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 239,265.00 |
| Dec 31, 2024 | 239,265.00 |
| Sep 30, 2024 | 237,773.00 |
| Sep 30, 2024 | 237,773.00 |
| Jun 30, 2024 | 188,185.00 |
| Jun 30, 2024 | 188,185.00 |
| Mar 31, 2024 | 188,843.00 |
| Mar 31, 2024 | 188,843.00 |
| Dec 31, 2023 | 196,354.00 |
| Dec 31, 2023 | 196,354.00 |
| Sep 30, 2023 | 139,992.00 |
| Sep 30, 2023 | 139,992.00 |